Analyst Reco. BiVictriX Therapeutics Plc

Equities

Market Closed - London S.E. Other stock markets 11:35:28 2024-05-20 am EDT			5-day change	1st Jan Change
10 ^GBX	-13.04%		-13.04%	-4.76%

Apr. 17	Bivictrix granted FDA orphan drug status for rare cancer treatment	AN
Apr. 17	BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment	MT

Bivictrix says BVX001 increases survival rates by more than double	23-10-12	AN
BiVictriX Therapeutics' Blood Cancer Drug Delivers Extended Survival Rates in Trial	23-10-12	MT
Bivictrix Therapeutics PLC Extended Survival Rates Reported With Bvx001 In A Pre-Clinical Model Of Acute Myeloid Leukaemia	23-10-12	RE

No results for this search